Rotavirus genotype distribution in Kyrgyzstan and Kazakhstan, 2007-2009

APMIS. 2013 May;121(5):447-55. doi: 10.1111/apm.12014. Epub 2012 Oct 19.

Abstract

This is the first study to present rotavirus genotype distribution in children admitted to a hospital with acute gastroenteritis in Kyrgyzstan and Kazakhstan from January 2007 through December 2009. In total, 858 rotavirus ELISA-positive samples were characterized by RT-PCR, with a considerable geographical and seasonal variation in genotype distribution observed during the study. The globally common genotypes (G1P[8], G2P[4], G3P[8], G4P[8], G9P[8], G12P[8] and G12P[6]) accounted for 81.5-88.2% of the infections in Kyrgyzstan and 72.3-79.3% of the infections in Kazakhstan. The predominant genotypes were G1P[8], G2P[4] and G3P[8]. G1P[8] was the dominating genotype in Kyrgyzstan, detected in 51-64.7% of the samples. A similar predominance was not seen for G1P[8] in Kazakhstan, with a shift to G2P[4] predominance being seen in 2008. G9P[8] was a rare genotype in both countries, whereas G12 was detected in between 2.2% and 7.6% of the samples. The surveillance period was characterized by many co-circulating genotypes, and eight unusual combinations (G1P[4], G2P[8], G2P[6], G3P[4], G9P[4], G12P[4], G9P[9] and G10P[4]) were detected. This study provides important baseline data on rotavirus genotypes in Kyrgyzstan and Kazakhstan in the pre-vaccine era, and the results may indicate that the two licensed vaccines can be expected to prevent rotavirus disease in these countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay
  • Epidemiological Monitoring
  • Feces / virology
  • Gastroenteritis / epidemiology*
  • Gastroenteritis / virology
  • Genotype*
  • Humans
  • Kazakhstan / epidemiology
  • Kyrgyzstan / epidemiology
  • Prevalence
  • Prospective Studies
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rotavirus / genetics*
  • Rotavirus / isolation & purification*
  • Rotavirus / pathogenicity
  • Rotavirus Infections / epidemiology*
  • Rotavirus Infections / prevention & control
  • Rotavirus Infections / virology
  • Rotavirus Vaccines / therapeutic use

Substances

  • Rotavirus Vaccines